AC Immune SA

Related Filers (8)

Other (166)

6-K
Monday, 1/22/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/3/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Thursday, 12/28/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 12/19/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Friday, 12/15/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 12/11/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/6/2023
Filing for proposed sale of securities under Rule 144
6-K
Friday, 12/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 8/22/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/17/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/9/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/8/2023
Filing for proposed sale of securities under Rule 144
6-K
Friday, 8/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 7/24/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 7/21/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 7/18/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 7/13/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 7/12/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/10/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 7/7/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/3/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 6/30/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 6/30/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 6/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/16/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 3/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/26/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/24/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 3/22/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 3/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/12/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/8/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/29/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/7/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/31/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/27/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/25/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/21/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 5/5/2021
Notice of Effectiveness
CORRESP
Monday, 5/3/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Wednesday, 4/28/2021
Registration statement for specified transactions by certain foreign private issuers
6-K
Wednesday, 4/28/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/31/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/23/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 3/23/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 2/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/11/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Monday, 11/23/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/23/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/18/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/13/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 11/5/2020
Notice of Effectiveness
CORRESP
Tuesday, 11/3/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Friday, 10/23/2020
Registration statement for specified transactions by certain foreign private issuers
6-K
Wednesday, 10/21/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/23/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/8/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/5/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/16/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/26/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/22/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/4/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/2/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/30/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Monday, 3/30/2020
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 3/23/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 1/17/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 12/20/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Wednesday, 11/13/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/6/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/20/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/14/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/1/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/17/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/11/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/4/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/15/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F/A
Friday, 4/19/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Show More

Ownership (30)

SC 13G/A
Friday, 2/9/2024
AFFIRIS AG in Liqu: Major Shareholders
SC 13G/A
Tuesday, 12/19/2023
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
AFFIRIS AG in Liqu: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 2/10/2023
dievini Hopp BioTech holding GmbH & Co KG: Major Shareholders
SC 13G/A
Friday, 1/27/2023
ELI LILLY & Co: Major Shareholders
SC 13G/A
Monday, 2/14/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Monday, 2/14/2022
EcoR1 Capital, LLC: Major Shareholders
SC 13G
Thursday, 8/5/2021
AFFiRiS AG: Major Shareholders
SC 13G/A
Friday, 2/12/2021
dievini Hopp BioTech holding GmbH & Co KG: Major Shareholders
SC 13G
Friday, 2/12/2021
ELI LILLY & Co: Major Shareholders
SC 13G
Friday, 1/22/2021
EcoR1 Capital, LLC: Major Shareholders
SC 13G/A
Thursday, 1/14/2021
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 2/14/2020
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 2/7/2020
FMR LLC: Major Shareholders
SC 13G/A
Thursday, 2/6/2020
dievini Hopp BioTech holding GmbH & Co KG: Major Shareholders
SC 13G/A
Monday, 9/16/2019
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Thursday, 3/21/2019
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Wednesday, 2/13/2019
FMR LLC: Major Shareholders
SC 13G/A
Tuesday, 2/12/2019
Varuma AG: Major Shareholders
SC 13G
Tuesday, 2/12/2019
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Monday, 2/4/2019
dievini Hopp BioTech holding GmbH & Co KG: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
Pfeifer Andrea: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
FMR LLC: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
Varuma AG: Major Shareholders
SC 13G
Tuesday, 2/14/2017
FMR LLC: Major Shareholders
SC 13G
Tuesday, 2/14/2017
dievini Hopp BioTech holding GmbH & Co KG: Major Shareholders
SC 13G
Tuesday, 2/14/2017
dievini Hopp BioTech holding GmbH & Co KG: Major Shareholders
SC 13G
Monday, 2/13/2017
Varuma AG: Major Shareholders
SC 13G
Monday, 2/13/2017
Pfeifer Andrea: Major Shareholders
Show More

Prospectus (22)

424B5
Friday, 12/15/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 5/19/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 5/5/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 9/8/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Monday, 8/5/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 7/20/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 7/19/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 7/17/2018
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Wednesday, 3/8/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 9/29/2016
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 9/23/2016
Prospectus filed pursuant to Rule 424(b)(4)
FWP
Wednesday, 9/21/2016
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Friday, 9/16/2016
Filing under Securities Act Rules 163/433 of free writing prospectuses
DRS/A
Friday, 4/29/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 4/29/2016
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 11/24/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Friday, 10/23/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 10/23/2015
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 10/2/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 10/2/2015
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 9/25/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Friday, 8/28/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Show More